The FDA has issued draft guidance on “Label Comprehension Studies for Nonprescription Drug Products.” The draft guidance provides recommendations on the design of label comprehension studies, which can be used to assess the extent to which consumers understand information conveyed by proposed nonprescription drug product labeling and then apply that information when making hypothetical drug use decisions. Comments on the draft are due July 30, 2009.